Number and function impairment of resident C-Kit+ cardiac stem cells in mice with renal dysfunction caused by 5/6 nephrectomy

References

• Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–2047
   PubMed Web of Science ®Google Scholar
• Guerin AP, Adda H, London GM, Marchais SJ. Cardiovascular disease in renal failure. Minerva Urol Nefrol. 2004;56:279–288
   Google Scholar
• Li Y, Takemura G, Okada H, et al. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure. J Card Fail. 2007;13:155–162
   Google Scholar
• Li Y, Wu J, He Q, et al. Angiotensin (1--7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice. Hypertens Res. 2009;32:369–374
   Google Scholar
• Urbanek K, Cesselli D, Rota M, et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA. 2006;103:9226–9231
   PubMed Web of Science ®Google Scholar
• Kajstura J, Urbanek K, Rota M, et al. Cardiac stem cells and myocardial disease. J Mol Cell Cardiol. 2008;45:505–513
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763–777
   PubMed Web of Science ®Google Scholar
• de Groot K, Bahlmann FH, Sowa J, et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int. 2004;66:641–646
   Google Scholar
• Choi JH, Kim KL, Huh W, et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol. 2004;24:1246–1252
   PubMed Web of Science ®Google Scholar
• Jacobi J, Porst M, Cordasic N, et al. Subtotal nephrectomy impairs ischemia-induced angiogenesis and hind limb re-perfusion in rats. Kidney Int. 2006;69:2013–2021
   PubMed Web of Science ®Google Scholar
• Yao EH, Yu Y, Fukuda N. Oxidative stress on progenitor and stem cells in cardiovascular diseases. Curr Pharm Biotechnol. 2006;7:101–108
   PubMed Web of Science ®Google Scholar
• Fazel S, Cimini M, Chen L, et al. Cardioprotective C-kit+ cells are from the Bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006;116:1865–1877
   PubMed Web of Science ®Google Scholar
• Li Y, Takemura G, Kosai K, et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation. 2003;107:2499–2506
   PubMed Web of Science ®Google Scholar
• Rota M, Padin-Iruegas ME, Misao Y, et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res. 2008;103:107–116
   PubMed Web of Science ®Google Scholar
• Guzman MJ, Crisostomo PR, Wang M, et al. Vascular endothelial growth factor improves myocardial functional recovery following ischemia/reperfusion injury. J Surg Res. 2008;150:286–292
   PubMed Web of Science ®Google Scholar
• Kawaguchi N, Smith AJ, Waring CD, et al. C-kitpos gata-4 high rat cardiac stem cells foster adult cardiomyocyte survival through igf-1 paracrine signalling. PLoS One. 2010;5:e14297
   Google Scholar
• Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res. 2005;97:663–673
   PubMed Web of Science ®Google Scholar
• Morishita R, Aoki M, Hashiya N, et al. Therapeutic angiogenesis using hepatocyte growth factor (hgf). Curr Gene Ther. 2004;4:199–206
   PubMed Web of Science ®Google Scholar
• Kawanishi S, Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann N Y Acad Sci. 2004;1019:278–284
   PubMed Web of Science ®Google Scholar
• Opresko PL, Fan J, Danzy S, et al. Oxidative damage in telomeric DNA disrupts recognition by trf1 and trf2. Nucleic Acids Res. 2005;33:1230–1239
   PubMed Web of Science ®Google Scholar
• Ito K, Hirao A, Arai F, et al. Reactive oxygen species act through p38 mapk to limit the lifespan of hematopoietic stem cells. Nat Med. 2006;12:446–451
   PubMed Web of Science ®Google Scholar
• Rota M, LeCapitaine N, Hosoda T, et al. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res. 2006;99:42–52
   PubMed Web of Science ®Google Scholar
• Song H, Cha MJ, Song BW, et al. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells. 2010;28:555–563
   PubMed Web of Science ®Google Scholar
• Barreto FC, Barreto DV, Liabeuf S, et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009;4:1551–1558
   PubMed Web of Science ®Google Scholar
• Tumur Z, Niwa T. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells. Am J Nephrol. 2009;29:551–557
   PubMed Web of Science ®Google Scholar